Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| METLIFE INCMET · Entity 488 | EVP & Chief Risk Officer | August 31, 2026 | September 02, 2026 |
| RAYMOND JAMES FINANCIAL INCRJF · Entity 3126 | Director | February 19, 2026 | February 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
METLIFE INC
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 150,350 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Tax withholding · Disposed 4,030 · Balance 150,350 F1: Withheld for taxes on shares issued for restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withheld for taxes on shares issued for restricted stock units.
RAYMOND JAMES FINANCIAL INC
Report date February 19, 2026 · Filed February 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,820 |
Reported balance
After 2026-02-19 transaction · row 1
1 source rowRow 1 · 2026-02-19 · Exercise / conversion · Acquired 1,253 · Balance 8,820 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,556 |
Reported balance
After 2026-02-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-19 · Grant · Acquired 1,303 · Balance 2,556 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,303 |
Reported balance
After 2026-02-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-19 · Exercise / conversion · Disposed 1,253 · Balance 1,303 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027.
F3: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 20:18 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 4,030 | $95.17 | $383,535.10 |
DisclosureSEC source: 0001770295-26-000011 · wk-form4_1788380321.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,350 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 10,712 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · derivative · entry 5 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,712 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 10,600 | $0.00 Strike: $46.85 | $0.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,600 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 21,312 | $81.59 | $1,738,822.64 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,380 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 10,712 | $45.50 | $487,396.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 10,600 | $46.85 | $496,610.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:02 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 4,133 | $73.24 | $302,700.92 |
DisclosureSEC source: 0001770295-26-000005 · wk-form4_1772658170.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,380 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:36 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 5,624 | $75.34 | $423,712.16 |
DisclosureSEC source: 0001770295-26-000003 · wk-form4_1772141787.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,513 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:36 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 14,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001770295-26-000003 · wk-form4_1772141787.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,137 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:36 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 15,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001770295-26-000003 · wk-form4_1772141787.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,267 F1 · price: Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionRestricted Stock Units · Derivative | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002377 · doc4.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,303 Underlying: Common Stock · 1,253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 1,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002377 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,556 Underlying: Common Stock · 1,303 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionCommon Stock | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002377 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:16 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,866 | $85.70 | $245,616.20 |
DisclosureSEC source: 0001099219-25-000073 · wk-form4_1741209407.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,135 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:19 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 12,706 | $82.20 | $1,044,433.20 |
DisclosureSEC source: 0001099219-25-000059 · wk-form4_1740691152.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,001 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:19 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 28,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-25-000059 · wk-form4_1740691152.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,707 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2022-2024 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:19 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 12,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-25-000059 · wk-form4_1740691152.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,281 F1 · price: Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:29 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionRestricted Stock Units · Derivative | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002287 · doc4.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,711 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:29 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002287 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,964 Underlying: Common Stock · 1,253 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2026. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2026. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:29 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002287 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 9,703 | $0.00 Strike: $45.91 | $0.00 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · derivative · entry 5 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,703 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 13,107 | $0.00 Strike: $34.33 | $0.00 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,107 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 22,810 | $82.88 | $1,890,577.20 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,507 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 9,703 | $45.91 | $445,464.73 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 13,107 | $34.33 | $449,963.31 |
DisclosureSEC source: 0001099219-24-000270 · wk-form4_1734470426.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:35 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,741 | $69.73 | $191,129.93 |
DisclosureSEC source: 0001099219-24-000072 · wk-form4_1709674518.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,507 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 17,896 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,896 Underlying: Common Stock · 17,896 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 16,206 | $69.16 | $1,120,806.96 |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,248 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 35,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,454 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 5,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,497 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 16:55 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionRestricted Stock Units · Derivative | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002880 · doc4.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,711 Underlying: Common Stock · 1,643 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 16:55 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002880 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,354 Underlying: Common Stock · 1,711 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2025. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 16:55 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002880 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 20:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 7,894 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-23-000217 · wf-form4_169394598322088.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,532 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 10,911 | $0.00 Strike: $45.15 | $0.00 |
DisclosureSEC source: 0001099219-23-000211 · wf-form4_169178500272865.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,911 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 25, 2015, 2016 and 2017. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:16 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 9,391 | $63.18 | $593,323.38 |
DisclosureSEC source: 0001099219-23-000211 · wf-form4_169178500272865.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,638 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 9, 2023 and related tax obligations and fees. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 20:16 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 10,911 | $45.15 | $492,631.65 |
DisclosureSEC source: 0001099219-23-000211 · wf-form4_169178500272865.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 23:55 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,548 | $71.27 | $181,595.96 |
DisclosureSEC source: 0001099219-23-000073 · wf-form4_167780128468623.xml · nonDerivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,118 F4 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:55 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 16,625 | $0.00 Strike: $71.73 | $0.00 |
DisclosureSEC source: 0001099219-23-000073 · wf-form4_167780128468623.xml · derivative · entry 5 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Underlying: Common Stock · 16,625 shares Expires 2033-02-27 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:55 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 14,368 | $71.73 | $1,030,616.64 |
DisclosureSEC source: 0001099219-23-000073 · wf-form4_167780128468623.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,666 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:55 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 32,193 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-23-000073 · wf-form4_167780128468623.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,034 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:55 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 5,542 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-23-000073 · wf-form4_167780128468623.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,841 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 16:19 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionRestricted Stock Units · Derivative | 1,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002837 · doc4.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 Underlying: Common Stock · 1,683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 16:19 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | GrantRestricted Stock Units · Derivative | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002837 · doc4.xml · derivative · entry 2 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,326 Underlying: Common Stock · 1,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F2 · derivative.exercise_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2024. F2 · derivative.expiration_date: The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2024. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 16:19 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionCommon Stock | 1,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002837 · doc4.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 5,513 | $0.00 Strike: $31.15 | $0.00 |
DisclosureSEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,513 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:20 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 4,060 | $67.60 | $274,456.00 |
DisclosureSEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,299 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 19, 2022 and related tax obligations and fees. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 5,513 | $31.15 | $171,729.95 |
DisclosureSEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:47 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 1,811 | $64.44 | $116,700.84 |
DisclosureSEC source: 0001099219-22-000050 · wf-form4_164634399023405.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,846 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 20:08 UTC | RAYMOND JAMES FINANCIAL INC RJF · Entity 3126 | Exercise / conversionRestricted Stock Units · Derivative | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003348 · doc4.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,683 Underlying: Common Stock · 1,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. F3 · derivative.exercise_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F3 · derivative.expiration_date: The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. F4 · balance_after: The RSU grant was previously reported as covering 1,283 shares awarded on February 18, 2021, but was adjusted to reflect the 3-for-2 stock split by means of a stock dividend that occurred on September 21, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.